📄 medicine

Sex- and Menopause-Related Differences in Immune and Gastrointestinal Symptom Architecture in ME/CFS: Evidence from Factor Analysis and Structural Equation Modeling

This study reveals that immune and gastrointestinal symptoms in ME/CFS exhibit distinct latent structures that differ by sex, with women showing separable but related immune and gut clusters that are differentially modulated by menopausal status, whereas men display a single integrated immune–gastrointestinal factor.

Original authors: Lotte Habermann-Horstmeier, Lukas Maximilian Horstmeier

Published 2026-06-30

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Lotte Habermann-Horstmeier, Lukas Maximilian Horstmeier

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

The Big Picture: Two Different Maps for One Disease

Imagine ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) as a massive, chaotic city where the lights are flickering, the traffic is jammed, and the power grid is unstable. Everyone in this city suffers from similar problems: they get sick easily (immune issues), their stomachs are upset (gut issues), they feel brain fog, and their bodies don't regulate temperature well.

For a long time, doctors and researchers looked at this city with a single map, assuming everyone's symptoms were connected in the same way.

This study, however, suggests that men and women are actually living in two different versions of this city. While they suffer from the same types of problems, the way those problems are "wired" together is fundamentally different.

The Core Discovery: Separate Rooms vs. One Big Hall

The researchers focused on two specific neighborhoods in this city: the Immune District (where flu-like feelings and infection susceptibility live) and the Gut District (where stomach pain and food intolerances live).

For Women: Two Separate Rooms

In women, the study found that the Immune District and the Gut District are like two separate rooms in a house.

They are connected by a hallway (they influence each other), but they are distinct.
You can have a problem in the Immune room without it immediately causing a crisis in the Gut room, and vice versa.
The Hormone Twist: The study also looked at women before and after menopause (the time when the body stops producing certain hormones). They found that the "Immune Room" is very sensitive to the hormonal thermostat.
- Premenopausal women (younger, higher hormones) had more "flu-like" symptoms. It's as if their immune system is like a high-sensitivity smoke detector that goes off easily.
- Postmenopausal women (older, lower hormones) had fewer flu-like symptoms. The smoke detector became less sensitive.
- However, the "Gut Room" didn't care about the hormones. Whether a woman was pre- or post-menopausal, her stomach issues remained the same. The Gut room is like a heavy, stubborn stone that doesn't move when the hormonal wind blows.

For Men: One Big Open Hall

In men, the study found that the Immune District and the Gut District are not separate rooms at all. They are one giant, open hall.

Everything is tightly connected. If the immune system flares up, the gut flares up immediately. They move in perfect lockstep.
The study suggests that for men, being susceptible to infections is the "master switch" that controls the whole hall.
The researchers noted that men's symptoms were more "integrated," meaning the problems were more synchronized than in women.

The "Why" Behind the Wiring (Theories, Not Proofs)

The paper doesn't prove exactly why this happens biologically (they didn't test blood or gut bacteria in this specific study), but they offer some interesting theories based on what we know about biology:

The Women's Path (The Vagal-Hormonal Network):
Think of women's bodies as having a sophisticated, hormone-sensitive security system. Estrogen (a hormone) acts like a volume knob for the immune system. When the knob is turned up (pre-menopause), the immune system reacts strongly to threats, causing flu-like feelings. But because the gut is a separate "room," it stays steady even when the immune volume changes.
The Men's Path (The Sympathetic-Metabolic Network):
Think of men's bodies as having a system driven by a "fight or flight" engine (sympathetic nervous system). In this engine, the immune system and the gut are gears in the same machine. If one gear turns, the other must turn. This creates a single, tight bundle of symptoms where infection susceptibility drives everything else.

What This Means for the "City"

Symptom Burden: Interestingly, the total amount of suffering wasn't necessarily different between men and women. Women just had more gut issues, while men and women had similar levels of immune issues. The difference wasn't how much they hurt, but how the pain was organized.
The Menopause Effect: The study highlights that for women, the immune part of their illness changes as they age and their hormones shift. But the gut part of their illness seems to be a chronic, long-term issue that stays the same regardless of age or hormones.

The Bottom Line

This research suggests that we cannot treat ME/CFS as a single, uniform condition for everyone.

For Women: We need to look at their immune and gut symptoms as two related but separate issues, keeping in mind that their hormones might be turning the "immune volume" up or down.
For Men: We need to look at their immune and gut symptoms as one single, tightly-woven package.

The authors conclude that understanding these different "wiring diagrams" is crucial. Just as you wouldn't try to fix a car engine with a hammer meant for a house, understanding these sex-specific patterns is the first step toward figuring out how to treat the disease effectively in the future.

Important Note from the Paper:
The authors are careful to say this is a "hypothesis-generating" study. They found these patterns in the data, but they did not directly measure the biological mechanisms (like specific bacteria or hormone levels) to prove why this happens. They are proposing these ideas as a roadmap for future research, not as a final medical rule.

Technical Summary: Sex- and Menopause-Related Differences in Immune and Gastrointestinal Symptom Architecture in ME/CFS

Problem Statement
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex multisystem disorder involving neuroimmune, autonomic, and gastrointestinal dysfunction. While previous research has identified coherent symptom domains (Brain, Autonomic, Gut, Immune) and noted sex-specific differences in neurocognitive and autonomic organization, the structural relationship between immune-related and gastrointestinal symptoms remains unclear. Specifically, it is unknown whether these symptoms form distinct latent clusters or an integrated structure in women versus men, and how menopausal status influences these symptom trajectories. This study (Study 4) aims to determine if Immune and Gut symptoms constitute separate clusters in women but a single integrated cluster in men, and to evaluate the impact of menopausal status on these domains.

Methodology
The study analyzed cross-sectional data from 748 adults (608 women, 137 men) with medically confirmed ME/CFS from the APAV-ME/CFS study.

Data Processing: Symptoms were coded as dichotomous variables (0 = absent, 1 = present). The analysis focused on four specific indicators: two Immune symptoms (flu-like symptoms, increased susceptibility to infections) and two Gut symptoms (gastrointestinal complaints, food intolerances).
Statistical Approach: Analyses were stratified by sex. The methodology included:
- Bivariate Associations: Cross-tabulations, Cramér's V, and tetrachoric correlations to assess pairwise symptom associations.
- Regression Models: Logistic and linear regression to evaluate predictive relationships and symptom burden.
- Factor Analysis: Exploratory Factor Analysis (EFA) with Varimax rotation to test for one-factor vs. two-factor solutions.
- Structural Equation Modeling (SEM): Confirmatory Factor Analysis (CFA) using Maximum Likelihood (ML) estimation in Stata 12.0 to compare model fit (CFI, RMSEA, SRMR) between a single-factor model (Combined Gut/Immune) and a two-factor model (separate Immune and Gut).
- Subgroup Analysis: Women were stratified by menopausal status (proxied by age: ≤50 vs. >50 years) to examine differences in symptom prevalence and duration effects.
Robustness Checks: Results were cross-validated using a stratified training dataset to ensure stability.

Key Results

Sex-Specific Latent Structures:
- Women: Immune and Gut symptoms formed two distinct, statistically separable clusters. While within-cluster correlations were moderate (tetrachoric $\rho$ = .47–.60), cross-cluster associations were weaker ( $\rho$ = .30–.35). SEM demonstrated that a two-factor model provided a significantly better fit (CFI = .913; RMSEA = .119) than a one-factor model, which showed poor fit.
- Men: All four symptoms loaded onto a single, integrated "Combined Gut/Immune" factor. Cross-domain correlations were consistently high ( $\rho$ = .43–.68). SEM confirmed an excellent fit for the one-factor model (CFI = .981; RMSEA = .074).
- Symptom Burden: While the structure of symptoms differed, the overall frequency and mean symptom scores for Immune symptoms did not differ significantly between sexes. However, women exhibited a higher overall symptom burden, driven exclusively by higher Gut symptom scores.
Impact of Menopause:
- Menopausal status selectively modulated Immune-related symptoms but not Gut symptoms.
- Immune Symptoms: Premenopausal women reported significantly higher frequencies of flu-like symptoms and susceptibility to infections compared to postmenopausal women. In postmenopausal women, these immune symptoms decreased as illness duration increased, whereas no such duration-dependent decline was observed in premenopausal women.
- Gut Symptoms: Gastrointestinal complaints and food intolerances remained stable across menopausal groups and increased with illness duration in both pre- and postmenopausal women, suggesting a progressive, hormonally independent trajectory.
Predictive Patterns:
- In men, susceptibility to infections emerged as the dominant predictor across all models, suggesting it is a central organizing feature of the integrated symptom cluster.
- In women, both immune and gut symptoms contributed to the prediction of flu-like symptoms, reflecting a more distributed predictive pattern.

Key Contributions

Structural Differentiation: The study provides statistical evidence that the latent architecture of ME/CFS symptoms is sex-dependent. It challenges the assumption of a uniform symptom structure, demonstrating that women exhibit a modular organization (separate Immune and Gut axes), while men exhibit a unified, integrated structure.
Hormonal Modulation: The research identifies a dissociation in how hormonal status affects symptom domains. It suggests that immune-related symptoms are dynamic and hormonally sensitive (specifically to estrogen status), whereas gastrointestinal symptoms represent a more stable, chronic pathology that progresses independently of menopausal transition.
Methodological Validation: By applying SEM and factor analysis to dichotomous symptom data, the study validates the existence of distinct symptom clusters that were previously hypothesized but not rigorously tested for sex-specific structural differences.

Significance and Claims
The authors claim that these findings support a dual-process model of ME/CFS pathophysiology:

Women: Operate via a "vagal–hormonal–inflammatory" pathway where immune and gut symptoms are distinct but interconnected, modulated by estrogen and disease stage.
Men: Operate via a "sympathetic–metabolic–vascular" pathway where immune vulnerability and gastrointestinal dysregulation are tightly coupled into a single latent construct.

The paper posits that these structural differences are not merely statistical artifacts but reflect underlying divergent neuroimmune–autonomic mechanisms. Consequently, the authors argue for sex-sensitive approaches in:

Phenotyping: Recognizing that symptom organization differs fundamentally by sex, even if prevalence rates are similar.
Mechanistic Research: Investigating distinct biological pathways (e.g., vagal tone and estrogen sensitivity in women vs. sympathetic overactivation in men).
Therapeutic Stratification: Suggesting that future interventions might need to be tailored to these specific architectures (e.g., targeting gut-barrier integrity and hormonal context in women vs. addressing sympathetic-metabolic coupling in men).

Limitations and Modesty
The authors explicitly state that these findings are hypothesis-generating rather than definitive mechanistic proof. Key limitations acknowledged include:

Proxy Measures: Menopausal status was estimated by age rather than direct hormonal measurement.
Data Type: Symptoms were self-reported and dichotomized, which may attenuate factor loadings.
Estimation Method: The use of Maximum Likelihood (ML) for binary data in SEM may introduce bias in fit indices, though cross-validation supported the robustness of the latent structure.
Causality: The cross-sectional design precludes causal inference regarding the temporal relationship between hormonal changes and symptom evolution.
Sample Size: The male subgroup (n=137) was relatively small for latent variable modeling, requiring cautious interpretation and future replication.

The study concludes that while the observed patterns strongly suggest sex-dependent neuroimmune–autonomic organization, direct biological validation (e.g., microbiome, cytokine profiles, autonomic physiology) is required to confirm the proposed mechanistic models.